Contribution of Recipient-Derived Cells in Allograft Neointima Formation and the Response to Stent Implantation
Open Access
- 26 March 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (3) , e1894
Abstract
Allograft coronary disease is the dominant cause of increased risk of death after cardiac transplantation. While the percutaneous insertion of stents is the most efficacious revascularization strategy for allograft coronary disease there is a high incidence of stent renarrowing. We developed a novel rabbit model of sex-mismatched allograft vascular disease as well as the response to stent implantation. In situ hybridization for the Y-chromosome was employed to detect male cells in the neointima of stented allograft, and the population of recipient derived neointimal cells was measured by quantitative polymerase chain reaction and characterized by immunohistochemistry. To demonstrate the participation of circulatory derived cells in stent neointima formation we infused ex vivo labeled peripheral blood mononuclear cells into native rabbit carotid arteries immediately after stenting. Fourteen days after stenting the neointima area was 58% greater in the stented vs. non-stented allograft segments (p = 0.02). Male cells were detected in the neointima of stented female-to-male allografts. Recipient-derived cells constituted 72.1±5.7% and 81.5±4.2% of neointimal cell population in the non-stented and stented segments, respectively and the corresponding proliferation rates were only 2.7±0.5% and 2.3±0.2%. Some of the recipient-derived neointimal cells were of endothelial lineage. The ex vivo tagged cells constituted 9.0±0.4% of the cells per high power field in the stent neointima 14 days after stenting. These experiments provide important quantitative data regarding the degree to which host-derived blood-borne cells contribute to neointima formation in allograft vasculopathy and the early response to stent implantation.Keywords
This publication has 43 references indexed in Scilit:
- Long-Term Results of Angioplasty Vs Stenting in Cardiac Transplant Recipients With Allograft VasculopathyThe Journal of Heart and Lung Transplantation, 2005
- Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosisCardiovascular Research, 2005
- Role of Progenitor Cells in Transplant ArteriosclerosisTrends in Cardiovascular Medicine, 2005
- Antagonism of the α4 integrin subunit attenuates the acute inflammatory response to stent implantation yet is insufficient to prevent late intimal formationJournal of Leukocyte Biology, 2004
- The porcine coronary model of in‐stent restenosis: Current status in the era of drug‐eluting stentsCatheterization and Cardiovascular Interventions, 2003
- Origin of Vascular Smooth Muscle Cells and the Role of Circulating Stem Cells in Transplant ArteriosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Engraftment assessment in human and mouse liver tissue after sex-mismatched liver cell transplantation by real-time quantitative PCR for Y chromosome sequencesLiver Transplantation, 2002
- Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathyThe Journal of Heart and Lung Transplantation, 2002
- Smooth Muscle Cells, But Not Myocytes, of Host Origin in Transplanted Human HeartsCirculation, 2002
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993